期刊文献+

TCRP1在慢性髓系白血病细胞中的表达及其对细胞增殖的影响 被引量:1

The expression of TCRP1 in chronic myeloid leukemia cells and its effects on cell proliferation
原文传递
导出
摘要 目的探讨舌癌耐药相关基因(TCRP1)在慢性髓系白血病细胞增殖中的可能作用,为探寻白血病的致病机制提供新思路。方法用实时定量PCR和Western blot的方法检测慢性髓系白血病患者外周血单核细胞(PBMC)和K562细胞系中TCRP1的表达,在K562细胞中干扰TCRP1的表达,用四氮唑蓝化合物(MTS)和软琼脂克隆形成实验来检测细胞的增殖,用Westernblot实验来检测蛋白激酶B(AKT)的表达及其磷酸化水平。结果在慢性髓系白血病患者PBMC中,TCRP1的mRNA和蛋白水平的表达量均高于正常对照(P〈0.05),MTS实验和软琼脂克隆形成实验结果表明干扰TCRP1表达后,K562细胞的增殖显著减慢(P〈0.05)。干扰TCRP1后,AKT蛋白的表达量不变,而其磷酸化水平显著降低(P〈0.05)。结论TCRP1在慢性髓系白血病细胞中高表达,TCRP1可能通过AKT的磷酸化水平来影响K562细胞的增殖。 Objective To investigate the effects of tongue cancer resistance-associated protein 1 ( TCRP1 ) in proliferation of chronic myeloid leukemia cells ( CML), and explore the new thoughts of patho- genesis of CML. Methods The expression of TCRP1 was detected in the peripheral blood mononuclear cells (PBMC) of CML with real-time quantitative polymerase chain reaction (PCR) and Western blot. After the expression of TCRP1 was interfered in K562 ceils, the proliferation of cells was detected by 3-(4,5- dimenthyhhiazol-2-yl) -5-( 3-carboxymethoxyphenyl ) -2-( 4-sulfophenyl ) -2H-tetrazolium ( MTS ) assay and soft agar colony forming assay, and the expression of protein kinase B (AKT) and its phosphorylation were tested by Western blot. Results In PBMC of CML patients, the mRNA and protein levels of TCRP1 were significantly higher than those of normal controls. The results of MTS assay and soft agar colony forming as- say showed that the proliferation of K562 cells was significantly decreased after the expression of TCRP1 was interfered. After knockdown of TCRP1 in K562 cells, the phosphorylation of AKT was significantly de- creased while the expression of total AKT did not change. Conclusions The expression of TCRP1 was in- creased in CML ceils. High expression of TCRP1 might contribute to proliferation of K562 cells via the phosphorylation of AKT.
出处 《中国医师杂志》 CAS 2017年第5期692-696,共5页 Journal of Chinese Physician
基金 深圳市2015年基础研究知识创新计划项目资助(JCYJ20150403100317057) 深圳市未来产业发展专项资金资助[深发改(2014)1712号]
关键词 癌基因 白血病 髓样 细胞增殖 舌肿瘤 Oncogenes Leukemia, myeloid Cell proliferation Tongue neoplasms
  • 相关文献

参考文献3

二级参考文献78

  • 1黄河,蔡真,林茂芳,谢万灼,梁彬,李黎,何静松,罗依,郑伟燕,张洁,叶琇锦,胡晓蓉,陈水云,金爱云.非亲缘异基因骨髓移植治疗儿童白血病[J].中华儿科杂志,2004,42(11):835-839. 被引量:7
  • 2贺其图,时风桐,袁祖正.包头市白血病流行病学调查[J].内蒙古医学杂志,1993,13(2):3-5. 被引量:10
  • 3江倩,陈珊珊,江滨,江浩,丘镜滢,刘艳荣,张艳,秦亚溱,陆颖,黄晓军,陆道培.甲磺酸伊马替尼治疗慢性粒细胞白血病慢性期100例追踪观察[J].中华血液学杂志,2006,27(11):721-726. 被引量:39
  • 4O' Brien S, Berman E, Borghaei H, et al. NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia. J Natl Cane Netw, 2009, 7:982-1023.
  • 5NCCN Clinical Practice Guidelines in Oncology (NCCN Guide- lines^TM )-FREE: Chronic Myelogenous Leukemia. Version 2. 2011[ 2011-03-29 ]. http//www. nccn. org/professionals/physi- cian_gls/f_guidelines. asp.
  • 6Baccarani M, Saglio G, Goldman J, et al. Evolving concepts in the management of chronic mycloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 2006, 108 : 1809-1820.
  • 7Baccarani M,Cortes J,Pane F, et al. Chronic myeloid leukemia, an update of concepts and management Recommendations of the Euro- peanLeukemiaNet. J Clin Oncol, 2009, 27:6041-6051.
  • 8World Health Organization Classification of Tumors. Pathology and Genetic of Tumors of Haematopoietic and Lymphoid Tissue. 2008.
  • 9Sokal JE, Baccarani M, Russo D, et al. Staging and prognosis in chronic myelogenous leukemia. Semin Hematol, 1988,25:49-61.
  • 10Schiffer CA. BCR-ABL tyrosine kinase inhibitors for chronic my- elogenous leukemia. N Engl J Med, 2007,357:258-265.

共引文献87

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部